Agricultural Chemistry

Bayer Turns Screws on Monsanto

The seed industry is experiencing a global slowdown.
  • Why it matters

    Why it matters

    Agricultural chemistry companies have been adversely affected by a slowdown in key agricultural regions. Monsanto has been worst affected, leaving Bayer in a strong position.

  • Facts


    • A Bayer acquisition of Monsanto would be the third megadeal in the agricultural sector in just a few months.
    • It follows the merger of Dow and Dupont in the United States, and the takeover of Swiss firm Syngenta by ChemChina.
    • Monsanto has repeatedly rejected Bayer’s offers, apparently holding out for a higher price.
  • Audio


  • Pdf

Hugh Grant’s plan was simple. In order to stave off a takeover bid from German chemicals giant Bayer, the boss of U.S. seed producer Monsanto put it about earlier this month that his firm could acquire the agricultural chemistry division of BASF, another German rival.

But that theoretical plan was scotched yesterday when BASF chief executive Kurt Bock clearly rejected the speculation that his company planned to sell its ag-chem unit. “I believe we have already made it very clear that our crop protection business is not for sale,” he said.

This is an inauspicious signal for Mr. Grant, who opposes a takeover offer from Bayer. He has now lost his key leverage tool.

A Monsanto takeover by Bayer would be the third megadeal in agricultural chemistry in just a few months. It would follow the merger of U.S. firms Dow Chemical and Dupont, as well as the purchase of Swiss seed maker Syngenta by Chemchina.

At the beginning of July, Bayer, based in Leverkusen in western Germany, raised its offer from $122 to $125 per share, which would amount to a total price of $64 billion (€58 billion). Monsanto rejects this offer, calling it “financially inadequate,” and is holding out for an even higher price.

Want to keep reading?

Subscribe now or log in to read our coverage of Europe’s leading economy.